Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
InvestorNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Secures $20M in Underwritten Public Offering
-
Siyata Mobile Announces Closing of $20 Million Underwritten Public Offering
-
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics
-
Siyata Mobile Announces Pricing of $20 Million Underwritten Public Offering
-
Iveda Files Form S-1 Registration Statement and Applies for NASDAQ Listing
-
Iveda Files Form S-1 Registration Statement and Applies for NASDAQ Listing
-
First Breach Bolsters Senior Management Team
-
Nexalin Technology, Inc (NXL) Files IPO Registration Statement
-
NexGel, Inc. Announces Closing of $14.2 Million Initial Public Offering
-
NexGel (NXGL) Prices 2.585M Share IPO at $5.50/sh
-
NexGel, Inc. Announces Listing on Nasdaq and Pricing of $14.2 Million Initial Public Offering
-
Titan Pharma (TTNP) Explores Strategic Alternatives
-
Titan Pharmaceuticals to Explore Strategic Alternatives
-
UPDATE: Maxim Group Starts Ayala Pharmaceuticals (AYLA) at Buy
-
Genenta Closes Its Upsized Initial Public Offering of American Depository Shares
-
Kairous Acquisition Corp. Closes $78.0 Million Initial Public Offering, Including Partial Exercise of the Overallotment Option
-
Kairous Acquisition Corp. Closes $78.0 Million Initial Public Offering, Including Partial Exercise of the Overallotment Option
-
Xeriant Provides Update on Recent & Upcoming Activities
-
Genenta S.p.A. (GNTA) IPO Opens 13% Lower
-
Fernhill Corp Engages Maxim Group LLC for Investment Banking Services
-
UPDATE: Maxim Group Starts ZIVO Bioscience, Inc. (ZIVO) at Buy
-
Genenta S.p.A. (GNTA) Prices Upsized 2.4M ADS IPO at $11.50/sh
-
Genenta Announces Pricing of Upsized Initial Public Offering
-
IPO for SPAC Kairous Acquisition Corp. (KACL) Opens at $10.06
-
Kairous Acquisition Corp. Limited (KACLU) Prices 7.5M Unit IPO at $10/unit
-
Kairous Acquisition Corp. Limited Pricing of $75 Million Initial Public Offering
-
Kairous Acquisition Corp. Limited Pricing of $75 Million Initial Public Offering
-
8i Acquisition 2 Corp. Announces the Separate Trading of its Ordinary Shares, Warrants and Rights, Commencing December 14, 2021
-
8i Acquisition 2 Corp. Announces the Separate Trading of its Ordinary Shares, Warrants and Rights, Commencing December 14, 2021
-
NeuroSense Therapeutics Announces Closing of Initial Public Offering on Nasdaq Capital Market
-
Maxim Group Starts WISeKey International (WKEY) at Buy
-
IPO for NeuroSense Therapeutics Ltd. (NRSN) Opened at $4.55
-
UPDATE: Maxim Group Starts Recruiter.com Group Inc. (RCRT) at Buy
-
NeuroSense Therapeutics Announces Pricing of $12 Million Initial Public Offering
-
As Global Cryptocurrency Wobbles, Market Value Still Projected To Reach $4.94 Billion By 2030
-
Hello Pal Engages Donohoe Advisory Associates LLC
-
Penny Stocks To Buy For Under $1 & What To Watch Right Now
-
mCloud Closes Over-Allotment Option for Underwritten Public Offering
-
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Research and Technology Progress, Offers Corporate Update
-
Avalon Acquisition Inc. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 3, 2021
-
Roth CH Acquisition V (ROCL) IPO Prices at $10
-
Roth CH Acquisition V Co. Announces Pricing of $100 Million Initial Public Offering
-
Atlanticus Closes Over-Allotment Option in connection with Offering of Senior Notes
-
Atlanticus Closes Over-Allotment Option in connection with Offering of Senior Notes
-
Fennec Pharmaceuticals Inc. (FENC) PT Lowered to $10 at Maxim Group, Following Clinical Business Update
-
UPDATE: Maxim Group Starts atai Life Sciences N.V (ATAI) at Buy
-
UPDATE: Maxim Group Starts Citius Pharmaceuticals (CTXR) at Buy
-
mCloud Announces Closing of USD$9.5 Million Underwritten Public Offering and Uplisting to Nasdaq
-
Phoenix Motors becomes latest EV maker looking to tap public markets
-
Phoenix Motor Inc (PEV) Files IPO Registration Statement

